Highlights for July 2017

  1. Panacea Bio collaborates with Bionpharma for generics worth $800M
  2. Sun Pharma & NIV sign agreement to fight Zika, Chikungunya and Dengue
  3. Glenmark Pharmaceuticals Enters Exclusive Agreement with Cyndea Pharma S.L. for Generic Soft-Gelatin Capsule Drug Products
  4. Takeda inks low-cost vaccine production tech  deal with Biological E
  5. Sayre Therapeutics in distribution agreement with Navidea for India
  6. Sun Pharma inks $55.5M deal with Samsung BioLogics
  7. Aagami client OncBioMune Acquires Propolis Product Line from German Partner
  8. Soon-Shiong’s NantCell in $356M deal for CytRx cancer drug
  9. LabCorp buys CRO Chiltern for $1.2B cash
  10. Emergent BioSolutions to Acquire ACAM2000® Business From Sanofi
  11. Lilly pays Nektar $150M upfront to buy into phase 1 drug with broad immune and inflammatory applications
  12. Jazz Pharmaceuticals and XL-protein GmbH Enter Into a License Agreement on PASylation® Technology to Develop Long-Acting Asparaginase Product Candidates

For more such news and updates, please join our Group "Global Life Science Business Partnering" on LinkedIn (https://www.linkedin.com/groups/4500189)